SEC Form 4 · accession 0001209191-19-011496
TANDEM DIABETES CARE INC · TNDM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kim D Blickenstaff
Officer — PRESIDENT & CEO · Director
Period of report
Feb 15, 2019
Accepted (ET)
Feb 20, 2019 · 4:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001438133
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF1,F2,F3 | $51.50 | Feb 15, 2019 | A | 210,000 | A | — | — | Common Stock | 210,000 | 210,000 | D |
Explanation of responses
- F1Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. The grant is contingent upon future stockholder approval of an increase in the number of shares reserved for issuance under the 2013 Stock Incentive Plan.
- F2The option shall vest as to twenty-five percent (25%) of the underlying shares on 2/15/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter.
- F3The expiration date for these options is ten (10) years from the date of grant.